Dennis M. O'Donnell
Gründer bei Primus Therapeutics, Inc.
Profil
Dennis M.
O'Donnell has founded Primus Therapeutics, Inc. in 2010, where he holds the title of President, Chief Executive Officer & Director.
He was also President of NextWave Pharmaceuticals, Inc. and held the title of SVP, GM-Respiratory, Gastrointestinal & Topical at Wyeth, Inc. Mr. O'Donnell holds an MBA from New York University and an undergraduate degree from St. John's University.
Aktive Positionen von Dennis M. O'Donnell
Unternehmen | Position | Beginn |
---|---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Gründer | 14.02.2011 |
Ehemalige bekannte Positionen von Dennis M. O'Donnell
Unternehmen | Position | Ende |
---|---|---|
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Präsident | 01.01.2009 |
NEW YORK HEALTH CARE, INC. | Präsident | 06.09.2006 |
Bio Balance Corp.
Bio Balance Corp. Miscellaneous Commercial ServicesCommercial Services Bio Balance Corp. is a private company that specializes in medical research and testing activities related to gastrointestinal diseases. The company is based in New York, NY and has subsidiaries in the United States. Bio Balance was acquired by Enterologics, Inc. from New York Health Care, Inc. on September 06, 2011 for $0.55 million. | Präsident | 01.01.2006 |
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Corporate Officer/Principal | - |
Ausbildung von Dennis M. O'Donnell
St. John's University | Undergraduate Degree |
New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEW YORK HEALTH CARE, INC. | Health Services |
Private Unternehmen | 4 |
---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Health Technology |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Health Technology |
Bio Balance Corp.
Bio Balance Corp. Miscellaneous Commercial ServicesCommercial Services Bio Balance Corp. is a private company that specializes in medical research and testing activities related to gastrointestinal diseases. The company is based in New York, NY and has subsidiaries in the United States. Bio Balance was acquired by Enterologics, Inc. from New York Health Care, Inc. on September 06, 2011 for $0.55 million. | Commercial Services |
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Health Technology |